Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching from TDF/FTC/EFV to TLD versus DTG/3TC in virologically suppressed Thai people with HIV
TCTR20221117001Phase 3Unknown
- Sponsor
- Mahasarakham University
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dolutegravir, tenofovir disoproxil fumarate, lamivudine in human immunodeficiency virus infection (HIV), sponsored by Mahasarakham University. Status: unknown.
02
Drugs
dolutegravirtenofovir disoproxil fumaratelamivudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on TCTR20221117001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221117001.